Welcome to Seacross Pharmaceuticals Ltd.
Oncology Injectable Other Product 1 Other Product 2
Irinotecan 20 mg/ml

Therapeutic indications: 

Irinotecan belongs to a group of medicines called cytostatics (anti-cancer medicines). It may be used alone or in combination with a number of other medicines used to treat cancer. These combinations may be used to treat cancers of the large intestine (colon or rectum) where the disease is at an advanced stage.

combination  with 5-fluorouracil/folinic acid (5FU/FA) and bevacizumab to treat cancer of the large intestine (colon or rectum).

combination with capecitabine with or without bevacizumab to treat your cancer of the colon and rectum.

combination  with cetuximab to treat cancer of the large intestine (KRAS wild-type) which expresses a protein called EGFR.

Form Concentrate for solution for infusion
Strength 40mg/2ml, 100mg/5ml,300mg/15ml, 500mg/25ml
Active substance Irinotecan
Other ingredients Sorbitol E420, lactic acid, water for injection, sodium hydroxide, hydrochloric acid (used to adjust the pH).
© Copyright - Clinico fusce blandit sapien eu